Homology Medicines FIXX

$ 0.93 0.77%

Quarterly report 2024-Q3
added 11-07-2024

Homology Medicines Financial Statements 2011-2024 | FIXX

Annual Financial Statements Homology Medicines

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	76.3 M	193 M	512 M	673 M	578 M	-	-	-	-	-	-	-
Shares	57.4 M	55.3 M	42.1 M	42.1 M	28.6 M	-	-	-	-	-	-	-
Historical Prices	1.33	3.49	10.7	16	29.5	-	-	-	-	-	-	-
Net Income	-5 M	-95.8 M	-129 M	-104 M	-57.2 M	-30 M	-8.05 M	-	-	-	-	-
Revenue	3.21 M	34 M	2.7 M	1.67 M	3.68 M	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-133 M	-95.9 M	-130 M	-110 M	-59.9 M	-29.7 M	-	-	-	-	-	-
Interest Expense	134 M	185 K	1.57 M	6.03 M	4.35 M	-334 K	-	-	-	-	-	-
EBITDA	-132 M	-87.6 M	-122 M	-104 M	-60.3 M	-29 M	-9.76 M	-	-	-	-	-
Operating Expenses	136 M	130 M	133 M	112 M	65.2 M	-	-	-	-	-	-	-
General and Administrative Expenses	38.1 M	36.8 M	32.6 M	22.2 M	17.3 M	8.28 M	4.31 M	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Homology Medicines

	2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	12.1 M	12 M	360 K	346 K	348 K	57.7 M	57.5 M	57.4 M	57.4 M	57.3 M	57.2 M	57.1 M	56.5 M	50.4 M	50.3 M	45.2 M	45.2 M	45.2 M	45.1 M	43.9 M	43.1 M	37.4 M	37.4 M	37.3 M	36.9 M	2.5 M	2.64 M	2.35 M	2.3 M	1.99 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-17.6 M	-17 M	-	-14 M	-5.81 M	-28.8 M	-	-33.7 M	-29.1 M	92.1 M	-	-30.6 M	-30.5 M	-1.07 M	-	-28.2 M	-35.3 M	-35.3 M	-	-29.6 M	-26.3 M	-23.9 M	-	-55.6 M	-55.6 M	-55.6 M	-	-6.53 M	-6 M	-5.55 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	1.86 M	3.2 M	802 K	-	802 K	802 K	802 K	-	1.68 M	2.19 M	29.3 M	-	567 K	567 K	588 K	-	441 K	392 K	270 K	-	5.32 M	5.32 M	823 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-18.8 M	-17.9 M	-	-7.8 M	-7.28 M	-27.5 M	-	-32.9 M	-28.3 M	-37.6 M	-	-30.7 M	-30.6 M	-1.11 M	-	-28.3 M	-35.7 M	-36.5 M	-	-31.3 M	-28 M	-25.1 M	-	-59.9 M	-59.9 M	-59.9 M	-	-6.66 M	-6.04 M	-4.69 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	1.22 M	2.39 M	-	84 K	165 K	1.47 M	-	1.27 M	474 K	131 M	-	53 K	52 K	38 K	-	41 K	357 K	1.16 M	-	1.66 M	1.7 M	1.27 M	-	1.49 M	996 K	479 K	-	137 K	35.8 K	-863 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-7.7 M	-7.08 M	-27.3 M	-	-32.6 M	-28 M	-37.3 M	-	-28.6 M	-28.5 M	969 K	-	-26.3 M	-33.7 M	-34.6 M	-	-29.6 M	-26.4 M	-23.9 M	-	-59.6 M	-59.7 M	-59.7 M	-	-6.46 M	-5.74 M	-4.56 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	18.8 M	17.9 M	-	9.66 M	10.5 M	28.3 M	-	33.7 M	29.1 M	38.4 M	-	32.3 M	32.7 M	30.4 M	-	28.8 M	36.3 M	37.1 M	-	31.7 M	28.4 M	25.4 M	-	17.2 M	14.8 M	11.8 M	-	6.66 M	6.04 M	4.69 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	4.47 M	4.51 M	-	2.19 M	2.46 M	8.32 M	-	7.81 M	8.03 M	14.1 M	-	8.35 M	9.04 M	8.66 M	-	8.42 M	8.79 M	7.77 M	-	6.04 M	5.54 M	4.86 M	-	3.84 M	4.53 M	3.83 M	-	1.72 M	1.98 M	1.89 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency